Rocket Lab stock has delivered a very large 3 year return while the latest valuation checks send a mixed message, with an intrinsic value estimate pointing to some upside and market based multiples suggesting the shares are not cheap.

• Rocket Lab has returned very close to 10x over the past 3 years, which puts extra focus on whether the current price still leaves enough room for future execution risk.
• The recent multi year launch contracts with the U.S. Space Force and iQPS can support expectations for future cash flows, while ongoing concerns around the balance sheet and liquidity may keep a discount in place if investors stay cautious.
• The company scores 3 of 6 on Simply Wall St's broader valuation checks. This points to a mixed picture rather than a clear bargain or clear overvaluation for Rocket Lab.

The issue now is whether the current share price already reflects those contract wins and long term growth hopes, or if the intrinsic value estimate still offers a reasonable margin of safety for new money.

Is Rocket Lab Still Cheap on Cash Flow?

The Discounted Cash Flow (DCF) model here is based on projected cash flows to Rocket Lab’s equity holders over two stages. Rocket Lab currently reports latest twelve month free cash flow of about $300.8 million in outflows, so the model assumes a recovery to positive cash flows over time. On those projections, the DCF model arrives at an estimated intrinsic value of about $81.76 per share.

That intrinsic value implies Rocket Lab screens around 13.9% undervalued relative to the prevailing share price. The recent $266 million multi year launch contract with the U.S. Space Force helps explain why the market is assigning some value to the company’s long term cash flow potential.

On this DCF view, Rocket Lab stock currently appears undervalued relative to its projected cash flows.

Our Discounted Cash Flow (DCF) analysis suggests Rocket Lab is undervalued by 13.9%. Track this in your watchlist or portfolio, or discover 52 more high quality undervalued stocks.

Does Rocket Lab Look Pricey on Book Value?

P/B is often a useful cross check for asset heavy businesses like Rocket Lab that invest heavily in launch sites, manufacturing and satellites. It compares what you pay in the market to the accounting value of the equity on the balance sheet.

Rocket Lab currently trades on a P/B of about 18.6x, which is far above the Aerospace & Defense industry average of around 3.8x and also above the peer group average of about 20.9x. That suggests investors are already paying a high price relative to Rocket Lab’s book value, despite ongoing questions around the balance sheet and liquidity.

On this metric, the stock appears richly priced rather than asset cheap, even after factoring in the multi year launch contracts and longer term ambitions.

Rocket Lab’s valuation looks high on a simple P/B comparison with both its industry and peers.

The Rocket Lab Narrative: What Would Justify Today's Price?

Simply Wall St Narratives pick up where Rocket Lab’s valuation puzzle leaves off. They spell out which assumptions on Rocket Lab’s future growth, margins and earnings would need to hold for the stock to be worth materially more or materially less than today’s price, and they sit on Simply Wall St’s Community page. Rather than relying on a single multiple or model output, each one lays out its own drivers so you can compare those assumptions with actual results over time.

Community views on Rocket Lab sit far apart, with one group seeing a long runway and the other focused on execution risk.

Bull case: 28% undervalued

"Rocket Lab USA seeks to vertically integrate itself throughout the $800 billion space 'backbone' in order to attract the customers operating within that $1 trillion top component of the 'space economy'…"

Bear case: 333% overvalued

"The entire valuation is 'priced for perfection,' which means any delay causes volatility…"

Do you think there's more to the story for Rocket Lab? Head over to our Community to see what others are saying!

The Bottom Line

The Discounted Cash Flow (DCF) view on Rocket Lab points to some undervaluation, yet the rich P/B multiple signals that the market already prices in ambitious growth and capital needs. The split between these methods mainly reflects different assumptions about how quickly cash flows can turn and how much investors will keep paying for those expectations after a very sharp share price move. With broader valuation checks looking mixed, the key question now is whether Rocket Lab can execute on its contracted pipeline and funding plans without diluting that intrinsic value case.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.